Evidence map›Paper›PMID 21986705›Full record

Trial reportInternational journal of obesity (2005)2012

Increased telomerase activity and vitamin D supplementation in overweight African Americans.

H Zhu, D Guo, K Li, J Pedersen-White, I S Stallmann-Jorgensen, Y Huang, S Parikh, K Liu, Y Dong

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of obesity (2005), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01141192 (The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults), which is not on this map. Cited by 37 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01141192 nacompletednot on this map

The Effect of Vitamin D Supplementation on Glucose Metabolism in Non-Diabetic African American Adults

TypeinterventionalSponsorAugusta UniversityRan2010 to 2010Enrolled48ConditionsType 2 DiabetesArmsvitamin D3, cholecalciferol, Inactive comparator
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 3 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Vitamin DThe American journal of clinical nutrition · 2025
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Can telomere length predict bone health? A review of current evidence.Bosnian journal of basic medical sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

H ZhuGeorgia Prevention Institute, Department of Pediatrics, Georgia Health Sciences University, Augusta, GA 30912, USA. hzhu@georgiahealth.edu
D Guo
K Li
J Pedersen-White
I S Stallmann-Jorgensen
Y Huang
S Parikh
K Liu
Y Dong
Augusta University · USAugusta University Health · USPrevention Institute · USWuhan University · CN

Funding

Vascular and renal responses to stressP01HL069999 · NHLBI · MEDICAL COLLEGE OF GEORGIA (MCG) · PI HARSHFIELD, GREGORY ALAN · 2002 to 2018
$31.1M
Genetics of Stress Induced Hypertension in Black YouthR01HL077230 · NHLBI · AUGUSTA UNIVERSITY · PI DONG, YANBIN · 2006 to 2009
$1.4M
NHLBI NIH HHS HL69999NHLBI NIH HHS HL77230NHLBI NIH HHS P01 HL069999NHLBI NIH HHS R01 HL077230
6 · The paper itself

Abstract

objectiveWe aimed to investigate whether vitamin D supplementation modulates peripheral blood mononuclear cell (PBMC) telomerase activity in overweight African Americans.

designA double blind, randomized and placebo-controlled clinical trial (#NCT01141192) was recently conducted. SUBJECTS AND

methodsAfrican-American adults were randomly assigned to either the placebo, or the vitamin D group (60,000 IU per month (equivalent to ~2000 IU per day) oral vitamin D3 supplementation). Fresh PBMCs were collected from 37 subjects (18 in the placebo group and 19 in the vitamin D group), both at baseline and 16 weeks. PBMC telomerase activity was measured by the telomeric repeat amplification protocol.

resultsSerum 25 hydroxyvitamin D levels increased from 40.7±15.7 at baseline to 48.1±17.5 nmol l(-1) at posttest (P=0.004) in the placebo group, and from 35.4±11.3 at baseline to 103.7±31.5 nmol l(-1) at posttests (P<0.0001) in the vitamin D group. In the vitamin D group, PBMC telomerase activity increased by 19.2% from baseline (1.56±0.29 absorbance reading unit (AU)) to posttest (1.86±0.42 AU, P<0.0001). The significance persisted after controlling for age, sex and body mass index (P=0.039). PBMC telomerase activity in the placebo group did not change from baseline (1.43±0.26 AU) to posttest (1.46±0.27 AU, P=0.157).

conclusionVitamin D supplementation significantly increased PBMC telomerase activity in overweight African Americans. Our data suggest that vitamin D may improve telomere maintenance and prevent cell senescence and counteract obesity-induced acceleration of cellular aging.

Indexed as

Black or African AmericanDietary SupplementsAdultAnalysis of VarianceCholecalciferolCross-Sectional StudiesDouble-Blind MethodFemaleGlycated HemoglobinHumansLeukocytes, MononuclearMaleMiddle AgedObesityTelomeraseTreatment Outcome25-hydroxyvitamin DCholecalciferolGlycated Hemoglobinhemoglobin A1c protein, humanTelomeraseVitamin D

Identifiers

PMID21986705
PMCPMC3826782
OpenAlexW1965995662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.